Liposomes: Structure, composition, types, and clinical applications

H Nsairat, D Khater, U Sayed, F Odeh, A Al Bawab… - Heliyon, 2022 - cell.com
Liposomes are now considered the most commonly used nanocarriers for various potentially
active hydrophobic and hydrophilic molecules due to their high biocompatibility …

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

JS Suk, Q Xu, N Kim, J Hanes, LM Ensign - Advanced drug delivery reviews, 2016 - Elsevier
Coating the surface of nanoparticles with polyethylene glycol (PEG), or “PEGylation”, is a
commonly used approach for improving the efficiency of drug and gene delivery to target …

Liposomal drug delivery systems: from concept to clinical applications

TM Allen, PR Cullis - Advanced drug delivery reviews, 2013 - Elsevier
The first closed bilayer phospholipid systems, called liposomes, were described in 1965 and
soon were proposed as drug delivery systems. The pioneering work of countless liposome …

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology

N Bertrand, J Wu, X Xu, N Kamaly… - Advanced drug delivery …, 2014 - Elsevier
Cancer nanotherapeutics are progressing at a steady rate; research and development in the
field has experienced an exponential growth since early 2000's. The path to the …

Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization

L van der Koog, TB Gandek… - Advanced healthcare …, 2022 - Wiley Online Library
Over the past decades, lipid‐based nanoparticle drug delivery systems (DDS) have caught
the attention of researchers worldwide, encouraging the field to rapidly develop improved …

Nanoparticle PEGylation for imaging and therapy

JV Jokerst, T Lobovkina, RN Zare, SS Gambhir - Nanomedicine, 2011 - Taylor & Francis
Nanoparticles are an essential component in the emerging field of nanomedical imaging
and therapy. When deployed in vivo, these materials are typically protected from the immune …

Stealth coating of nanoparticles in drug-delivery systems

SY Fam, CF Chee, CY Yong, KL Ho… - Nanomaterials, 2020 - mdpi.com
Nanoparticles (NPs) have emerged as a powerful drug-delivery tool for cancer therapies to
enhance the specificity of drug actions, while reducing the systemic side effects …

Liposomal nanomedicine: applications for drug delivery in cancer therapy

F Rommasi, N Esfandiari - Nanoscale Research Letters, 2021 - Springer
The increasing prevalence of cancer, a disease in which rapid and uncontrollable cell
growth causes complication and tissue dysfunction, is one of the serious and tense concerns …

PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

M Ogris, S Brunner, S Schüller, R Kircheis, E Wagner - Gene therapy, 1999 - nature.com
We investigated the in vitro and in vivo properties of DNA/transferrin–polyethylenimine (800
kDa) complexes before and after covalent coupling of poly (ethylene glycol)(PEG). Upon …

The journey of a drug-carrier in the body: an anatomo-physiological perspective

N Bertrand, JC Leroux - Journal of controlled release, 2012 - Elsevier
Recent advances in chemistry and material sciences have witnessed the emergence of an
increasing number of novel and complex nanosized carriers for the delivery of drugs and …